Publications by authors named "Luisa Ferri"
Cardiovasc Toxicol
June 2024
Article Synopsis
- Trastuzumab, used for treating HER2+ breast cancer, can lead to left ventricular dysfunction, indicated by a drop in global longitudinal strain (GLS) which predicts cardiotoxicity.
- Significant early changes in left atrial function were observed in patients during treatment, suggesting a potential link to later cardiotoxic effects.
- The study found that declines in early peak atrial longitudinal strain (PALS) and peak atrial contraction (PACS) could effectively predict the risk of developing cancer therapy-related cardiotoxicity, providing valuable insights for monitoring patients.
